For other functions project: acquisition of colony stimulating factor(s) (g-CSF or GM-CSF) for mitigation of neutropenia arising from exposure to ionizing radiation (rtor-CSF-0003)
Ended Awarded Last action
- Contract number
- HHSO10033003T
- Awardee
-
Partner Therapeutics, Inc. UEI J33MSDBJZMC6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $37,626,711
Award facts
- Opportunity
-
- 12100SOL00016 Solicitation number
- Acquisition of Colony Stimulating Factor(s) (G-CSF or GM-CSF) for mitigation of Neutropenia arising from exposure to ionizing radiation Award Notice · Posted Sep 30, 2016
- Contract value 100% obligated
- $37,626,711.32 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bridgewater, NJ 08807, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $2,211 | |
| Other Administrative Action | $0 | |
| Original award | $37,624,500 |
About this award
This is a federal contract award to Partner Therapeutics, Inc., a biopharmaceutical company based in Lexington, Massachusetts, to provide a colony stimulating factor (G-CSF or GM-CSF) as a medical countermeasure for treating neutropenia arising from exposure to ionizing radiation. The contract, awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR), has a ceiling value of $37,626,711.32 and an ultimate completion date of September 30, 2021. This is a delivery order under the HHS Colony Stimulating Factor 2013-2018 master Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which allows for streamlined task order awards to Partner Therapeutics based on its capabilities in supportive care and medical countermeasures. The contract has a firm fixed price pricing type and does not contain any set-aside requirements.
Quick answers
Who was awarded contract HHSO10033003T?
HHSO10033003T was awarded to Partner Therapeutics, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2016.
How much is contract HHSO10033003T worth?
The government has obligated $37,626,711 on HHSO10033003T.
Is contract HHSO10033003T an order under another contract?
Yes. HHSO10033003T is a delivery order under HHSO100201300005I, an indefinite delivery contract, on HHS Colony Stimulating Factor 2013-2018.
Was contract HHSO10033003T competed?
The extent of competition for HHSO10033003T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award